Financhill
Sell
9

PCSA Quote, Financials, Valuation and Earnings

Last price:
$3.10
Seasonality move :
-30.99%
Day range:
$3.10 - $3.35
52-week range:
$2.74 - $20.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.22x
Volume:
35.6K
Avg. volume:
1.6M
1-year change:
-81.64%
Market cap:
$7.1M
Revenue:
--
EPS (TTM):
-$26.88

Earnings Data

Next earnings date for PCSA
--
Most recent earnings per share
-$1.81
Beat by $0.19
(Sep 30/2025)
Consensus Estimate
-$2.00
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PCSA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 -- -- -- -$1.50 --
09/30/2025 Q3 -- -- -$1.81 -$2.00 $0.19
08/13/2025 Q2 -- -- -$6.32 -$5.75 -$0.57
05/08/2025 Q1 -- -- -$0.30 -$19.25 $18.95
12/31/2024 Q4 -- -- -$18.45 -$23.00 $4.55
10/30/2024 Q3 -- -- -$1.03 -$25.00 $23.97
08/13/2024 Q2 -- -- -$1.01 -$24.50 $23.49
05/10/2024 Q1 -- -- -$1.11 -$29.50 $28.39
03/29/2024 Q4 -- -- -$1.87 -$40.00 $38.13
11/13/2023 Q3 -- -- -$1.54 -- --
06/30/2023 Q2 -- -- -$1.94 -- --
03/31/2023 Q1 -- -- -$3.53 -- --
12/31/2022 Q4 -- -- -$16.23 -- --
09/30/2022 Q3 -- -- -$7.43 -- --
06/30/2022 Q2 -- -- -$6.48 -- --
03/31/2022 Q1 -- -- -$4.08 -- --
12/31/2021 Q4 -- -- -$4.06 -- --
09/30/2021 Q3 -- -- -$3.85 -- --
06/30/2021 Q2 -- -- -$4.10 -- --
03/31/2021 Q1 -- -- -$2.88 -- --
12/31/2020 Q4 -- -- -$33.89 -- --
09/30/2020 Q3 -- -- -$10.98 -- --
06/30/2020 Q2 -- -- -$2.66 -- --
03/31/2020 Q1 -- -- -$3.17 -- --
12/31/2019 Q4 -- -- -$4.67 -- --
09/30/2019 Q3 -- -- -$3.12 -- --
06/30/2019 Q2 -- -- -$3.51 -- --
03/31/2019 Q1 -- -- -$2.72 -- --
12/31/2018 Q4 -- -- -$2.21 -- --
09/30/2018 Q3 -- -- -$3.09 -- --
06/30/2018 Q2 -- -- -$4.20 -- --
03/31/2018 Q1 -- -- -$4.20 -- --
12/31/2017 Q4 -- -- -$6.09 -- --
09/30/2017 Q3 -- -- -$549.05 -- --
06/30/2017 Q2 -- -- -$245.00 -- --
03/31/2017 Q1 -- -- -$245.00 -- --
12/31/2016 Q4 -- -- -- -- --
09/30/2016 Q3 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- $5K -- -- --

Processa Pharmaceuticals, Inc. Earnings Questions

  • How Much did Processa Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Processa Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Processa Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Processa Pharmaceuticals, Inc. announced earnings per share of -$1.81 which represents a beat of analyst forecast a -$2.00 per share.

  • Is Processa Pharmaceuticals, Inc. Profitable?

    Processa Pharmaceuticals, Inc. reported -$300 that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Processa Pharmaceuticals, Inc. EPS Next Year?

    Processa Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$96.82 per share to -$10.75 per share next year representing a decrease of -88.9%.

  • When is Processa Pharmaceuticals, Inc.'s Earnings Date?

    Currently, Processa Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on April 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
73
BNAI alert for Jan 27

Brand Engagement Network, Inc. [BNAI] is up 279.19% over the past day.

Buy
71
GLSI alert for Jan 27

Greenwich LifeSciences, Inc. [GLSI] is up 19.36% over the past day.

Sell
48
RVMD alert for Jan 27

Revolution Medicines, Inc. [RVMD] is down 16.89% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock